First Trust Advisors’s Dianthus Therapeutics DNTH Stock Holding History

First Trust Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.18M	Buy	+94,152	New	+$8.22M	0.01%	1248
2022 Q3	–	Sell	-3,455	Closed	-$66K	–	2506
2022 Q2	$66K	Sell	3,455 -93	-3%	-$2.3K	﹤0.01%	2468
2022 Q1	$165K	Sell	3,548 -206	-5%	-$11.3K	﹤0.01%	2485
2021 Q4	$266K	Buy	3,754 +475	+14%	+$47.7K	﹤0.01%	2409
2021 Q3	$382K	Buy	+3,279	New	+$382K	﹤0.01%	2336

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

First Trust Advisors's DNTH Position: Q2 2026 in Review

First Trust Advisors opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 94,152 shares worth $9.18M. The stake represents 0.01% of the portfolio and ranks #1248 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in DNTH as recently as Q2 2022.

First Trust Advisors first reported a position in DNTH in Q3 2021 and has held it in 5 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

First Trust Advisors held 94,152 shares of Dianthus Therapeutics worth $9.18M as of Q2 2026.
Dianthus Therapeutics was a new First Trust Advisors position in Q2 2026.
Dianthus Therapeutics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1248 holding.
First Trust Advisors first reported a position in Dianthus Therapeutics in Q3 2021 and has held it in 5 quarters since.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.